CD103⁺ cells at the forefront of anticancer immunity

Oncoimmunology. 2017 Jul 31;6(11):e1356154. doi: 10.1080/2162402X.2017.1356154. eCollection 2017.

Authors

Claire Vanpouille-Box¹, Lorenzo Galluzzi^{1

2

3}

Affiliations

¹ Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
² Sandra and Edward Meyer Cancer Center, New York, NY, USA.
³ Université Paris Descartes/Paris V, Paris, France.

No abstract available

Keywords: BATF3; PD-1; PD-L1; cytotoxic T lymphocytes; dendritic cells; immune checkpoint blockers.

Publication types

Editorial
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't